^
    No biomarker
    Mantle Cell Lymphoma
    brexucabtagene autoleucel
    Sensitive
    :
    A1
    No biomarker
    Mantle Cell Lymphoma
    ICP-022
    Sensitive
    :
    A1
    No biomarker
    Mantle Cell Lymphoma
    lenalidomide
    Sensitive
    :
    A1
    No biomarker
    Mantle Cell Lymphoma
    zanubrutinib
    Sensitive
    :
    A1
    No biomarker
    Mantle Cell Lymphoma
    temsirolimus
    Sensitive
    :
    A1
    No biomarker
    Mantle Cell Lymphoma
    ibrutinib
    Sensitive
    :
    A1
    No biomarker
    Mantle Cell Lymphoma
    rituximab + bortezomib
    Sensitive
    :
    A1
    No biomarker
    Mantle Cell Lymphoma
    acalabrutinib
    Sensitive
    :
    A1
    No biomarker
    Mantle Cell Lymphoma
    venetoclax + ibrutinib
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    rituximab
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    bendamustine
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    rituximab + lenalidomide
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    bortezomib
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    venetoclax
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    rituximab + ibrutinib + lenalidomide
    Sensitive
    :
    A2
    ALK negative
    Mantle Cell Lymphoma
    brentuximab vedotin
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    VR-CAP
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    R-DHAP
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    R-DHAX
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    R-CVAD
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    R-GemOx
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    venetoclax + rituximab
    Sensitive
    :
    A2
    No biomarker
    Mantle Cell Lymphoma
    R-CHOP
    Sensitive
    :
    A2
    CCR7 positive
    Mantle Cell Lymphoma
    brexucabtagene autoleucel
    Sensitive
    :
    B
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES